Clinical Trials Directory

Trials / Sponsors / Codagenix, Inc

Codagenix, Inc

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingSafety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children
Respiratory Syncytial Virus Infections
Phase 12023-03-28
WithdrawnA Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer
Breast Neoplasms, Neoplasm Metastasis
Phase 12023-01-15
CompletedSafety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19
COVID-19, SARS-CoV-2
Phase 12022-04-14
CompletedIntramuscular CodaVax-H1N1 in Healthy Adults
Influenza, Human
Phase 12022-04-11
CompletedSafety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19
COVID-19
Phase 12020-12-11
CompletedSafety and Immunogenicity of a Live-attenuated Vaccine Against Respiratory Syncytial Virus in Elderly Voluntee
Respiratory Syncytial Virus Infections
Phase 12020-07-10
CompletedSafety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray
Influenza
Phase 12019-05-07
CompletedSafety Study of Live Attenuated Influenza Vaccine, CodaVax
Influenza
Phase 12017-02-21